Home›Guide

Guide

How to sell your pre-IPO startup shares or vested options in the US and Europe

Start here: What every founder & employee should know about their startup equity — the plain-English field guide to what you hold, what it's worth, and the deadlines that cost money.

If you hold shares — or vested options — in a private startup, you don't always have to wait for an IPO or an acquisition to see any cash. Here's how selling a small part of your stake early actually works, in plain terms.

The steps below apply the same way in the US and Europe — only the tax and local rules differ. For those: selling shares in the United States · getting liquidity in Europe.

What a secondary sale is

A secondary is simply selling shares you already own to a private buyer. The money goes to you, not to the company. You don't have to sell everything — most people sell a small slice for some liquidity now and keep the rest. It's the opposite of a "primary" round, where new shares are issued and the cash goes into the business.

Deep dive: how to get cash out of your startup equity without waiting for an exit →

Who can sell — and why they do

Founders and co-founders, employees and former employees holding shares (or exercised options), and early angels can all sell part of a stake. People do it for very ordinary reasons:

It's your equity. Wanting a little liquidity is normal — and, once any restrictions are cleared, entirely your right.

If you hold options (ESOP), read this first

Options are not shares yet. You usually have to exercise them — pay to convert them into real shares — before you can sell. If you have left the company, there is often a deadline to do this (frequently around 90 days), and exercising can trigger a tax bill.

Mind the deadline and the tax. Check your plan documents for the exercise window, and speak to an adviser about the tax before you act — the numbers can be meaningful.

Deep dive: can an ex-employee sell startup shares? →

Can the shares be transferred? (ROFR & board approval)

Most shareholder agreements include a right of first refusal (ROFR) and require board or company approval before a transfer. A ROFR lets the company or existing shareholders buy your shares first, usually on the same terms as your outside buyer.

This is normal, not a dead end. You simply clear it with your company first. It is the seller's job, and it is usually routine.

Deep dive: can I sell my startup shares before an exit or IPO? →

What are they worth?

Secondaries are usually priced off your company's last funding round, at a discount for a quick, private, all-cash sale — often somewhere between 10% and 40%, depending on demand and how much you want to sell. Our free estimator gives you a rough figure in seconds, and the "Can I sell?" check tells you whether your shares are ready to go.

Deep dive: how much are my startup shares worth? →

Deep dive: what discount is fair when you sell startup shares? →

Why a private buyer wants in

It helps to understand the other side. Private investors buy secondaries because it gets them:

Deep dive: who buys private startup shares — and how to sell yours →

Deep dive: stuck with shares you can't sell? What to actually do →

That's why the right buyer is often glad to hear from you — you're offering something they can't easily find.

How PrivateTechShares helps

We're an education and tools service — not a broker or marketplace. We help you understand and prepare your private-company equity: free calculators to estimate what your stake might be worth and what exercising options would cost, plain-English country guides on transfer rules and tax, and a step-by-step preparation toolkit. We don't find buyers, hold shares or money, or advise on or take a cut of any transaction — you stay in control of the whole process.

Want to get prepared?

Start with the free calculators and guides, or go deeper with the equity toolkit — it walks you through valuing your stake, the documents to gather, the transfer restrictions to check and the tax to plan for.

Get the equity toolkit →

General information only — not legal, tax or investment advice, and not an offer to buy or sell securities. Rules differ by company and country; take professional advice before acting.